Relay Therapeutics
NASDAQ: RLAYCambridge, US · 2 known investors
Improving patients' lives by accelerating development and commercialization of medicines that matter.
Biotech
Founders & leadership
TC
Thomas CatinazzoExecutive Officer
PR
Peter RahmerExecutive Officer
SK
Sekar KathiresanDirector
DS
Douglas S. IngramDirector
SK
Sanjiv K. PatelExecutive Officer, Director
MM
Mark MurckoDirector
LS
Laura ShawverDirector
BA
Brian AdamsExecutive Officer
LH
Linda HillDirector
JR
Jami RubinDirector
DA
Donald A. BergstromExecutive Officer
AB
Alexis BorisyDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$30MraisedJan 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$30MraisedJan 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas CatinazzoExecutive Officer
- Peter RahmerExecutive Officer
- Sekar KathiresanDirector
- Douglas S. IngramDirector
- Sanjiv K. PatelExecutive Officer, Director
- Mark MurckoDirector
- Laura ShawverDirector
- Brian AdamsExecutive Officer
- Linda HillDirector
- Jami RubinDirector
- Donald A. BergstromExecutive Officer
- Alexis BorisyDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.